Family Medicine, McMaster University, Hamilton, Ontario, Canada
Family Medicine, McMaster University, Hamilton, Ontario, Canada.
BMJ Open. 2019 Sep 20;9(9):e027897. doi: 10.1136/bmjopen-2018-027897.
The purpose of this randomised trial is to evaluate the efficacy of a decision support intervention for serious illness decisions (the Plan Well Guide decision aid; www.PlanWellguide.com) in increasing the engagement of substitute decision-makers (SDMs) in the patient's advance care planning process (ie, 'ACP engagement'), specifically the SDM's confidence and readiness for the role in the future.
This study is a parallel group randomised controlled trial. We aim to enrol 90 participant dyads: patients aged 65 years and older attending outpatient healthcare settings and with indicators they would be at high risk of needing future medical decisions and their SDM. The intervention is the Plan Well Guide decision aid, administered to the patient by a facilitator, with the SDM present. The primary endpoint is change after 3 months in the SDM's ACP engagement using a validated measure of behavioural change (SDM's knowledge, contemplation, self-efficacy and readiness) to enact the role. The secondary endpoints are (1) ACP engagement of the patient measured by a validated survey; (2) change in SDM decisional conflict regarding involvement in future decision-making and (3) postintervention patient decisional conflict regarding preference for life-sustaining treatments. Primary and secondary continuous outcomes will be analysed using the linear regression. The mean difference and 95% CIs will be reported.
Approval was received August 2017 (2017-3714-GRA) from the Hamilton Integrated Research Ethics Board. We plan to disseminate trial results in peer-reviewed journals, at national and international conferences, and via our web-based knowledge translation platforms.
NCT03239639; Pre-results.
本随机试验的目的是评估一项针对重病决策的决策支持干预措施(即 Plan Well Guide 决策辅助工具;www.PlanWellguide.com)的疗效,以增加替代决策者(SDM)参与患者的预先护理计划过程(即“ACP 参与”),特别是 SDM 对未来角色的信心和准备情况。
本研究是一项平行组随机对照试验。我们旨在招募 90 对参与者:年龄在 65 岁及以上的门诊医疗保健环境中的患者,以及有迹象表明他们将来可能需要进行医疗决策的患者及其 SDM。干预措施是 Plan Well Guide 决策辅助工具,由一名协调员在 SDM 在场的情况下为患者提供。主要终点是在 3 个月后,使用经过验证的行为改变测量方法(SDM 的知识、思考、自我效能和准备)来衡量 SDM 的 ACP 参与度的变化,以实施该角色。次要终点是(1)通过经过验证的调查衡量患者的 ACP 参与度;(2)SDM 对未来决策参与的决策冲突的变化;(3)干预后患者对维持生命治疗的偏好的决策冲突。主要和次要连续结果将使用线性回归进行分析。将报告平均值差异和 95%置信区间。
2017 年 8 月获得汉密尔顿综合研究伦理委员会的批准(2017-3714-GRA)。我们计划在同行评议的期刊、国家和国际会议以及我们的基于网络的知识转化平台上发布试验结果。
NCT03239639;预结果。